private digital health companies obesity management glp-1 Nutritional priorities to support therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Medicine Association, and The Obesity Society Designing fiscally viable coverage of

After 28 days, throw it away, even if there is some medicine left in the pen

What the CDSCO said on May 18, 2026 The Central Drugs Standard Control Organisation (CDSCO) is India's national regulatory authority under the Ministry of Health and Family Welfare

One such example is glucagon-like peptide 1 (GLP-1) (3.3 kDa), a small peptide hormone with a plasma half-life of only two minutes due to enzymatic degradation by dipeptidyl peptidase-4 (DDP-4) in the blood and rapid excretion through the kidneys 16,17,18,19

CVS recent choice marks a reversal from its decision last year to exclude Zepbound from its commercial formularies while maintaining coverage for Novo Nordisks Wegovy following a negotiation for more favorable pricing terms with the Danish drugmaker

The effect of tirzepatide during weight loss on metabolic adaption, fat oxidation, and food intake in people with obesity

With specialized medication to treat nausea, an anti-inflammatory, and a pro-motility agent to aid in fast recovery